8-K: Cartica Acquisition Corp Schedules Special Shareholder Meeting
Shareholder Meeting Announcement
Cartica Acquisition Corp announced a Special Meeting for October 3, 2025, to address shareholder nominations and other business.
Summary
- Cartica Acquisition Corp will hold an extraordinary general meeting in lieu of an annual general meeting of shareholders (the "Special Meeting") on Friday, October 3, 2025, at 10:00 a.m. Eastern Time.
- The meeting will take place at the offices of Ellenoff Grossman & Schole LLP at 1345 Avenue of the Americas, 11th Floor, New York, New York 10105, and shareholders can attend in person or virtually via the Internet.
- Shareholders wishing to bring proposals before the Special Meeting must submit them to the Company by September 15, 2025.
- All shareholder proposals must comply with the laws of the Cayman Islands, U.S. Securities and Exchange Commission (SEC) regulations, and the Company's amended and restated memorandum and articles of association.
- Only business outlined in the definitive proxy statement, which will be filed with the SEC, may be transacted at the Special Meeting.
Sentiment
Score: 5
Explanation: The filing is a neutral, procedural announcement regarding a shareholder meeting and nomination process, with no explicit positive or negative financial or operational news.
Future Outlook
NA
Industry Context
Cartica Acquisition Corp is a Special Purpose Acquisition Company (SPAC). Such meetings are common for SPACs, often related to extending deadlines for a business combination, approving a de-SPAC transaction, or addressing corporate governance matters like director nominations as they approach or execute a merger. This announcement signals standard corporate governance procedures for a publicly traded entity.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Shareholder Nomination Process | Announcement of an extraordinary general meeting in lieu of an annual general meeting, including the process and deadline for shareholder proposals and director nominations. | 2025-10-03 | Establishes the formal process for shareholder engagement and potential director nominations, adhering to the company's Memorandum and Articles of Association and regulatory requirements. |
Stakeholder Impact
- Shareholders: Provides notice of an upcoming meeting where they can participate, vote, and potentially submit proposals for consideration.
Next Steps
- Cartica Acquisition Corp will file a definitive proxy statement with the SEC detailing the business to be transacted at the Special Meeting.
- Shareholders must submit any proposals by September 15, 2025.
- The Special Meeting will be held on October 3, 2025.
Key Dates
| Date | Description |
|---|---|
| 2025-09-04 | Date of report and announcement of the Special Meeting. |
| 2025-09-15 | Deadline for shareholders to deliver proposals for the Special Meeting. |
| 2025-10-03 | Date of the Extraordinary General Meeting in lieu of an annual general meeting of shareholders. |
Recommendation
holdThis filing is a standard procedural announcement for a shareholder meeting, primarily focused on corporate governance and the process for shareholder nominations. It does not contain any material financial or operational news that would warrant a change in investment recommendation. Investors should hold their position and await the definitive proxy statement for details on the specific proposals to be voted upon, which may then influence a revised recommendation.
Keywords
Cartica Acquisition Corp, Special Meeting, Shareholder Meeting, Proxy Statement, Corporate Governance, SPAC, Shareholder Nominations, 8-K Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.